Impact Factor
3.60
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.32
800 total citations
h5-index
35
h5 depth signal
Cited share
80.0%
196 of 245
Total citations
800
Citation footprint
Metric signal
2.96
External metric anchor
Self-citation
2.8%
22 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
413
Italy
159
United Kingdom
117
China
91
Germany
90
Citing Fields of Research
Cardiology
355
Musculoskeletal Disorders
135
Vascular Disorders
127
Postural Control
86
Medical Ethics
78
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,248
Articles tracked across the journal lifetime
Indexed publication set
245
196 cited publications
Last 12 months
138
11.5 publications/month
Open access share
26.1%
36 OA publications in the last year
Leading citing country
United States
413 citing publications
Leading citing field
Cardiology
355 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Sept. 2004-
v1n1, Sept. 2004-
Active Coverage
Research Focus & Classification
Indexed Subjects
Cardiology
Musculoskeletal Disorders
Medical Ethics
Vascular Disorders
Ophthalmology
Postural Control
Broad Categories
Diagnostic Imaging
Therapeutics
Cardiology
Vascular Disorders
Musculoskeletal Disorders
Postural Control
Ophthalmology
Medical Ethics
MeSH Descriptors
Equipment Design
Equipment and Supplies
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1080/17434440.2026.2751750
Open DOI
Cell-free corneal stromal implants: a fit-for-purpose medical-device framework
02
DOI 10.1080/17434440.2026.2749360
Open DOI
Mechanical ventilation before and during veno-venous extracorporeal membrane oxygenation
03
04
DOI 10.1080/17434440.2026.2750592
Open DOI
Blurred boundaries: should drug-device interactions be reported under pharmacovigilance, materiovigilance, or both?
1. The existing safety surveillance system draws a clear administrative line between pharmacovigilance (PV) and materiovigilance (MV), which captures adverse reactions attributable to medicinal pro...
05
06
DOI 10.1080/17434440.2026.2740306
Open DOI
Pattern and texton-based feature descriptors for diabetic foot ulcer detection
07
DOI 10.1080/17434440.2026.2743929
Open DOI
Advances in non-invasive monitoring of drug delivery for neurodegenerative disorders
08
DOI 10.1080/17434440.2026.2746135
Open DOI
Safety and efficacy of indigenous ultrathin-strut versus international thin-strut drug-eluting coronary stents in percutaneous coronary intervention: a systematic review of randomized controlled trials
1. According to the World Health Organization (WHO) Mortality Database, cardiovascular diseases account for approximately 17.9 million deaths annually worldwide, with more than 1 million Acute Coro...
09
10
DOI 10.1080/17434440.2026.2741518
Open DOI
Selection of central venous access devices for neonates: an expert review
Bibliographical & Catalog Notes
Title from cover.
Description based on: Vol. 2, no. 1 (Jan. 2005); title from cover.
Also issued online.